Eli Lilly & Co. (LLY)

• Annual Data
• Quarterly Data

Eli Lilly & Co., Common-Size Consolidated Statement of Financial Position, Assets (quarterly data)

Based on: 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-07-25), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-20), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-05-01), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-30), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-19), 10-Q (filing date: 2014-10-29), 10-Q (filing date: 2014-07-28), 10-Q (filing date: 2014-04-28), 10-K (filing date: 2014-02-19), 10-Q (filing date: 2013-10-30), 10-Q (filing date: 2013-07-26), 10-Q (filing date: 2013-04-26).

Item	Description	The company
Current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Eli Lilly & Co.’s current assets as a percentage of total assets increased from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018.
Property and equipment, net of accumulated depreciation	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Eli Lilly & Co.’s property and equipment, net of accumulated depreciation as a percentage of total assets increased from Q1 2018 to Q2 2018 but then declined significantly from Q2 2018 to Q3 2018.
Noncurrent assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.	Eli Lilly & Co.’s noncurrent assets as a percentage of total assets declined from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018.